Overview
Pfeiffer syndrome is a rare genetic disorder characterized by the premature fusion of certain skull bones (craniosynostosis), broad and medially deviated thumbs and great toes, and variable degrees of syndactyly (webbing) of the hands and feet. It belongs to a group of conditions known as craniosynostosis syndromes and is caused by gain-of-function mutations in the FGFR1 (fibroblast growth factor receptor 1) gene on chromosome 8 or, more commonly, the FGFR2 gene on chromosome 10. The condition affects multiple body systems, including the skeletal, central nervous, and respiratory systems. Pfeiffer syndrome is classified into three clinical subtypes. Type 1 (classic Pfeiffer syndrome) is the mildest form, featuring bicoronal craniosynostosis resulting in brachycephaly, midface hypoplasia, broad thumbs and great toes, and generally normal to near-normal intelligence. Types 2 and 3 are more severe. Type 2 is characterized by a cloverleaf skull deformity (Kleeblattschädel), severe proptosis (bulging eyes), and significant neurological complications. Type 3 is similar to Type 2 but without the cloverleaf skull, and both severe forms carry a higher risk of early death due to respiratory compromise, increased intracranial pressure, and brain abnormalities. Additional features across subtypes may include hearing loss, hydrocephalus, dental abnormalities, and elbow ankylosis or other limb anomalies. There is no cure for Pfeiffer syndrome, and management is multidisciplinary. Treatment typically involves staged surgical interventions, including cranial vault remodeling to relieve intracranial pressure, midface advancement surgery to address airway obstruction and proptosis, and hand and foot surgery to improve function. Tracheostomy may be required in severe cases to maintain the airway. Long-term care involves craniofacial surgeons, neurosurgeons, ophthalmologists, otolaryngologists, audiologists, and developmental specialists. Outcomes vary significantly by subtype, with Type 1 patients generally having a favorable prognosis, while Types 2 and 3 are associated with substantial morbidity and mortality.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Pfeiffer syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Pfeiffer syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Pfeiffer syndrome.
Community
No community posts yet. Be the first to share your experience with Pfeiffer syndrome.
Start the conversation →Latest news about Pfeiffer syndrome
No recent news articles for Pfeiffer syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Pfeiffer syndrome
What is Pfeiffer syndrome?
Pfeiffer syndrome is a rare genetic disorder characterized by the premature fusion of certain skull bones (craniosynostosis), broad and medially deviated thumbs and great toes, and variable degrees of syndactyly (webbing) of the hands and feet. It belongs to a group of conditions known as craniosynostosis syndromes and is caused by gain-of-function mutations in the FGFR1 (fibroblast growth factor receptor 1) gene on chromosome 8 or, more commonly, the FGFR2 gene on chromosome 10. The condition affects multiple body systems, including the skeletal, central nervous, and respiratory systems. Pfe
How is Pfeiffer syndrome inherited?
Pfeiffer syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Pfeiffer syndrome typically begin?
Typical onset of Pfeiffer syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Pfeiffer syndrome?
7 specialists and care centers treating Pfeiffer syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.